MSC Industrial grants Walter Siegel 2,282 options

Q: How many options and RSUs did Walter Siegel receive from MSM?

Walter Siegel was granted 2,282 options and 1,097 RSUs on November 3, 2026.

Q: What is the vesting schedule for Walter Siegel’s MSM awards?

Of the options, 570 shares become exercisable on each of November 3, 2027 and November 3, 2028, and 571 shares on each of November 3, 2029 and November 3, 2030. Of the RSUs, 274 vest on each of November 3, 2027, November 3, 2028, and November 3, 2029, and 275 vest on November 3, 2030, provided Siegel remains continuously employed through each applicable date.

The options become exercisable in installments through November 3, 2030; RSUs vest on the same dates subject to continued employment.

Available on EDGAR 11/05/2026 - 02:23 PM EST Accepted by SEC EDGAR 11/05/2026 - 02:22 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

MSC Industrial Direct Co Inc (MSM) reported that Walter Siegel, SVP, Gen Counsel & Corp Sec, was granted 2,282 options and 1,097 restricted stock units (RSUs) on November 3, 2026. The options have a $120.30 per-share exercise price and become exercisable in installments from November 3, 2027, through November 3, 2030. The RSUs vest over the same dates, provided he remains continuously employed through each applicable vesting date; vested shares are delivered upon vesting.

Insider Trade Summary

Grant/Award: 3,379 shares

Grant/Award 2 txns

Insider Siegel Walter

Role SVP, Gen Counsel & Corp Sec

Type	Security	Shares	Price	Value
Grant/Award	Options (right to buy) ^{F1, F2}	2,282	$0.00	$0.00
Grant/Award	Restricted Stock Units (RSU) ^{F3, F4}	1,097	$0.00	$0.00

Holdings After Transaction: Options (right to buy) — 2,282 contracts (Direct); Restricted Stock Units (RSU) — 1,097 contracts (Direct)

Holdings Before and After: Options (right to buy), 0 to 2,282 contracts (Direct); Restricted Stock Units (RSU), 0 to 1,097 contracts (Direct)

Footnotes (4)

F1. Represents options to purchase the Issuer's Class A Common Stock, $0.001 par value ("Common Stock").
F2. An option to purchase 2,282 shares of the Issuer's Common Stock was issued to the Reporting Person under the Issuer's 2023 Omnibus Equity Plan. 570 shares of Common Stock become exercisable on each of November 3, 2027 and November 3, 2028, and 571 shares of Common Stock become exercisable on each of November 3, 2029 and November 3, 2030.
F3. Each RSU represents a contingent right to receive one share of Common Stock.
F4. 1,097 RSUs were granted on November 3, 2026. 274 RSUs vest on each of November 3, 2027, November 3, 2028, and November 3, 2029, and 275 RSUs vest on November 3, 2030, provided that the Reporting Person remains continuously employed by the Issuer through each applicable vesting date. The vested shares will be delivered to the Reporting Person upon vesting.

Key Figures

Options granted: 2,282 options Option exercise price: $120.30 per share Options becoming exercisable: 570 shares on each of November 3, 2027 and November 3, 2028 +5 more

8 metrics

Options granted 2,282 options November 3, 2026

Option exercise price $120.30 per share Options granted November 3, 2026

Options becoming exercisable 570 shares on each of November 3, 2027 and November 3, 2028 Option grant

Options becoming exercisable 571 shares on each of November 3, 2029 and November 3, 2030 Option grant

RSUs granted 1,097 RSUs November 3, 2026

RSUs vesting 274 RSUs on each of November 3, 2027, November 3, 2028, and November 3, 2029 Subject to continuous employment through each applicable vesting date

RSUs vesting 275 RSUs on November 3, 2030 Subject to continuous employment through the vesting date

Option expiration date November 2, 2036 Options granted November 3, 2026

Key Terms

2023 Omnibus Equity Plan, Restricted Stock Units (RSU), contingent right, exercisable

4 terms

2023 Omnibus Equity Plan financial

"under the Issuer's 2023 Omnibus Equity Plan"

Restricted Stock Units (RSU) financial

"Restricted Stock Units (RSU)"

contingent right financial

"Each RSU represents a contingent right to receive one share"

exercisable financial

"570 shares of Common Stock become exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options and RSUs did Walter Siegel receive from MSM?

Walter Siegel was granted 2,282 options and 1,097 RSUs on November 3, 2026.

What is the vesting schedule for Walter Siegel’s MSM awards?

Of the options, 570 shares become exercisable on each of November 3, 2027 and November 3, 2028, and 571 shares on each of November 3, 2029 and November 3, 2030. Of the RSUs, 274 vest on each of November 3, 2027, November 3, 2028, and November 3, 2029, and 275 vest on November 3, 2030, provided Siegel remains continuously employed through each applicable date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siegel Walter

(Last)

(First)

(Middle)

C/O MSC INDUSTRIAL DIRECT CO., INC.

515 BROADHOLLOW ROAD

(Street)

MELVILLE

NEW YORK

11747

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MSC INDUSTRIAL DIRECT CO INC [ MSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Gen Counsel & Corp Sec

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Options (right to buy)⁽¹⁾	$120.3	11/03/2026		A		2,282		⁽²⁾	11/02/2036	Class A Common Stock, $0.001 par value	2,282	$0	2,282	D
Restricted Stock Units (RSU)	⁽³⁾	11/03/2026		A		1,097		⁽⁴⁾	⁽⁴⁾	Class A Common Stock, $0.001 par value	1,097	$0	1,097	D

Explanation of Responses:

1. Represents options to purchase the Issuer's Class A Common Stock, $0.001 par value ("Common Stock").

2. An option to purchase 2,282 shares of the Issuer's Common Stock was issued to the Reporting Person under the Issuer's 2023 Omnibus Equity Plan. 570 shares of Common Stock become exercisable on each of November 3, 2027 and November 3, 2028, and 571 shares of Common Stock become exercisable on each of November 3, 2029 and November 3, 2030.

3. Each RSU represents a contingent right to receive one share of Common Stock.

4. 1,097 RSUs were granted on November 3, 2026. 274 RSUs vest on each of November 3, 2027, November 3, 2028, and November 3, 2029, and 275 RSUs vest on November 3, 2030, provided that the Reporting Person remains continuously employed by the Issuer through each applicable vesting date. The vested shares will be delivered to the Reporting Person upon vesting.

Remarks:

	/s/ Walter Siegel	11/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR